coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Woking Wise 2 PCN, Woking · Health Inequalities Profile

    PCN U53317 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    43,728

    Registered population

    65.1% aged 18–64

    13.9%

    Aged 65+

    ICB 18.8% · England 17.9%

    27.0%

    Ethnic minority (non-White)

    20.9% Asian · England 9.6%

    1.6%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~630

    Core20 residents (est.)

    Resident basis; registered basis ~655 · see page 3

    5,304

    Hypertension register

    +5.67% in 3 yrs · England +5.60%

    370

    SMI register

    36.8% of Woking's

    489

    COPD register

    Reviews +0.62% in 3 yrs

    Forecast to 2030

    6,535

    Hypertension patients, 2030

    +1,231 on today

    72.1%

    QRISK ≥20% on statins, 2030

    +3.40pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    17
    Seventeen of twenty-five three-year trends trail England.

    Non-frail diabetes HbA1c control fell 0.6% (England +4.4%) and mental health BMI recording rose +1.4 pp (England +5.1 pp), which may warrant recall review.

    85.6%
    Pre-school booster coverage sits below 95.0% target.

    MMR dose 2 is 85.6% (below the 95.0% target by 9.4 pp) and 4-in-1 is 82.2%, which may reflect unverified recall gaps.

    73.1%
    Strong clinical delivery on existing disease registers.

    Hypertension target control is 73.1% (England 70.3%) and asthma reviews reach 69.5% (England 65.7%), though recorded hypertension prevalence is 12.0% (England 15.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 20.9% Asian residents alongside 36.8% of Woking's mental illness register

    Across four constituent practices, WOKING WISE 2 PCN serves 43,728 registered patients. Only 13.9% (6,062 patients) are aged 65+ (Woking 15.3%, NHS Surrey Heartlands Integrated Care Board 18.8%, England 17.9%), while 65.1% are aged 18-64 (28,475 patients; Woking 63.4%, ICB 60.8%, England 62.7%) and 21.0% aged 0-17 (9,191 patients; Woking 21.3%, ICB 20.4%, England 19.6%). In the resident catchment, 20.9% are Asian or Asian British (Woking 14.2%, ICB 7.7%, England 9.6%), reaching 28.4% at Maybury Surgery. These ethnic proportions reflect Census usual residents rather than GP-registered patients.

    Age profile

    0–1721.0%
    18–6465.1%
    65+13.9%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White73.0%
    Asian20.9%
    Other2.3%
    Mixed2.2%
    Black1.6%

    Older people · falls rows are Woking local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Woking LA)1,8542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)57.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Woking LA)7969819552024/25
    Falls deaths, all ages, per 100,000 (Woking LA)11.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low overall, with Core20 patients concentrated at Sunny Meed Surgery

    Woking Wise 2 PCN has low relative deprivation with an average IMD decile of 7.2 (Woking 7.8, NHS Surrey Heartlands Integrated Care Board 7.9, England 5.5). Registered Core20 prevalence is 1.6% (Woking 1.5%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 21.0%), though weighted practice rates reconcile to 1.5%. Deprivation concentrates in Sunny Meed Surgery (2.2% share; 322 estimated patients) and Hillview Medical Centre (1.2% share; 182 estimated patients). Proactive Core20 outreach can focus on these two practices where local deprivation and estimated patient volume concentrate.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Sunny Meed2.2% · 322 patients
    Southview Medical1.4% · 151 patients
    Hillview1.2% · 182 patients
    Maybury0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    370

    SMI register

    0.84% recorded prevalence

    236

    Learning disability register

    0.53% recorded prevalence

    17

    Care homes, 571 beds

    In the PCN catchment

    8.3%

    Provide unpaid care

    Woking, Census 2021

    Severe mental illness prevalence is 0.8% (370 patients; Woking 0.8%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 1.0%) and learning disability is 0.5% (236 patients; Woking 0.5%, ICB 0.5%, England 0.6%), representing 36.8% and 38.4% of Woking's registers. Catchment care homes total 17 with 571 beds. The network holds over a third of Woking's recorded severe mental illness and learning disability patients.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reached 81.9% (England 83.4%), while BMI checks reached 82.2% (England 82.1%). Three-year BMI check growth of +1.4 pp trailed England (+5.1 pp). Complete annual health checks were not captured.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,304

    Hypertension register

    +5.67%

    Register growth, 3 yrs

    Woking +6.51% · England +5.60%

    +2.05pp

    BP control, under 80

    ≤140/90 · −0.22pp aged 80+

    +1,231

    More patients by 2030

    Forecast 6,535 (13.40%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 12.0% (5,304 patients), trailing Woking (13.2%), NHS Surrey Heartlands ICB (14.3%), and England (15.2%), with an unadjusted register gap range of +477 to +1,356 patients. Slower prevalence may reflect a younger list (13.9% aged 65+ versus 17.9% in England). Among diagnosed patients, clinical management is strong: 92.3% had a recent blood pressure reading (England 90.0%) and 73.1% are treated to target (England 70.3%), although control in patients aged 80 and over fell 0.3% over three years (England +2.2%). Lower recorded prevalence than England may reflect demographic differences or unverified detection gaps, which age-stratified audits could test.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 64.7%, exceeding England (63.6%), Woking (61.7%), and NHS Surrey Heartlands ICB (59.4%). Statin therapy for diabetes without cardiovascular disease is 70.0%, below England (73.2%). Lower diabetic statin therapy than England indicates an opportunity to review recall for eligible patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202641,588£2.10£2.24£1.86£87,335
    Cardiovascular (all), 202555,781£5.22£4.74£3.33£291,177

    In 2026, lipid-modifying drugs cost £2.10 per item across 41,588 items (£87,335 spend), compared with £1.86 in England, £2.50 in Woking, and £2.24 in NHS Surrey Heartlands ICB, spending £9,981 more than at England's unit cost. This unit-cost indicator does not account for case-mix or formulary choices, but highlights an area for local prescribing review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.65%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.01%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 1.1% (489 patients), trailing England (1.9%), Woking (1.2%), and NHS Surrey Heartlands ICB (1.3%), and fell 0.6% over three years (England +2.6%). Asthma prevalence is 5.3% (2,179 patients; England 6.6%), having fallen 1.0% over three years (England +0.5%). Conversely, 12-month review rates exceed national benchmarks: COPD reviews reached 78.9% (England 76.4%) and asthma reviews reached 69.5% (England 65.7%), leaving an estimated 664 asthma patients unreviewed. Contracting registers alongside high review rates could reflect unverified coding attrition, testable by clinical audit.

    Cancer register and children's immunisation

    Cancer prevalence is 3.4% (1,487 patients; England 3.8%). Childhood immunisation shows strong early uptake, with 6-in-1 reaching 96.6% at 24 months, above the 95.0% target. By age five, coverage falls below target: MMR dose 2 is 85.6% (9.4 pp below the 95.0% target) and the 4-in-1 booster is 82.2% (12.8 pp below target), showing a 5.9 pp MMR dose difference.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.1%

    England 91.0%

    6-in-1 complete primary course at 24 months96.6%

    England 92.2%

    MMR dose 1 at 24 months93.1%

    England 88.3%

    MMR dose 2 at age 585.6%

    England 82.8%

    4-in-1 pre-school booster at age 582.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In NHS Surrey Heartlands ICB, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2 in 2022, which is 6.1 percentage points above England (55.3%) but 13.6 percentage points below the 75.0% national ambition. Known-stage completeness was 67.7% (4,810 of 7,106 cancers). At PCN level, breast screening coverage is 64.9% (England 69.9%, ICB 71.2%), while cervical screening in women aged 25 to 49 is 67.4% (ICB 69.3%), falling 2.0% over three years (England -1.0%). Practice cervical coverage includes 58.8% at Southview Medical Practice and 60.1% at Maybury Surgery. System staging describes wider performance, not PCN delivery.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Ashford and St Peter's Hospitals NHS Foundation Trust achieved 76.4% on the 62-day cancer referral to treatment standard in Jul 2026 (provisional), below the 85.0% standard but above England (71.2%) and NHS Surrey and Sussex Integrated Care Board (71.5%), while Royal Surrey NHS Foundation Trust reached 84.5% and Frimley Health NHS Foundation Trust 81.8%. The trust met the 28-day faster diagnosis standard at 85.5% (standard 75.0%). For diagnostics, 6-week waits reached 49.6% for colonoscopy (England 30.8%) and 57.9% for flexi sigmoidoscopy (England 32.1%).

    Pathways within standard (%)Ashford and St Peter'sRoyal SurreyFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5382.6287.9579.2979.32
    31-day treatment (96%)94.2196.4392.8990.4592.50
    62-day referral to treatment (85%)76.3884.4881.8471.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sRoyal SurreyFrimley HealthEngland
    MRI0.090.0012.8521.40
    CT9.270.150.639.92
    Echocardiography0.971.553.3528.48
    Colonoscopy49.610.0022.8430.83
    Gastroscopy56.740.007.4329.02
    All 15 DM01 tests23.128.827.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). For Woking borough residents, community health services recorded 109,530 contacts in Jun 2026 (provisional), with adults aged 65 and over accounting for 69.6% (76,215 contacts). Activity is captured at local authority level across NHS Surrey Heartlands Integrated Care Board rather than by PCN, highlighting substantial community-based clinical touchpoints concentrated among older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 25.6 pp alongside a 23.3 pp spread in vaccination achievement

    In 2025/26, overall QOF achievement ranges from 87.1% at Southview Medical Practice to 96.8% at Sunny Meed Surgery (England 92.5%). Vaccination achievement spans 23.3 pp, from 49.9% at Southview Medical Practice to 73.2% at Sunny Meed Surgery (England 55.2%), while personalised care adjustments reach 14.4% at Maybury Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Maybury Surgery930.058.9%62.0%79.1%
    Southview Medical1291.447.5%69.8%74.2%
    Hillview991.235.9%66.0%65.8%
    Sunny Meed Surgery1102.233.3%67.8%65.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWokingAssetPCNWoking
    Care homes (catchment)17 (571 beds)n/aSchools (catchment)69n/a
    Children's centres68Places of worship3949
    Librariesn/a1Homelessness support (VCS)0no data
    Day centres (VCS)22Carers support groups (VCS)11
    Primary schools (LA maintained)12Primary academies1519
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school booster recall and catch-up

    Age-5 MMR2 coverage is 85.6% (below the 95.0% target by 9.4 pp; ICB 87.0%, England 82.8%) and 4-in-1 is 82.2% (below target by 12.8 pp), with a 5.9 pp MMR dose difference across 118 children. Low cost, quick to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 2

    Age-stratified hypertension case-finding audit

    Recorded hypertension prevalence is 12.0% (5,304 patients) against 13.2% in Woking, 14.3% in ICB, and 15.2% in England, giving an unadjusted gap range of +477 to +1,356 patients. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Respiratory register validation and asthma recall

    COPD prevalence is 1.1% (489 patients vs Woking 1.2%, England 1.9%; unadjusted gap +25 to +339), falling 0.6% over three years; 69.5% asthma review coverage leaves 664 of 2,179 patients unreviewed. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored outreach review (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical and breast screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice phone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Pre-school booster recall and catch-up (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5MHIS · From Harm to HopePCN
    Option 2 · Age-stratified hypertension case-finding audit (p12)Hypertension register · Hypertension: QOF prevalence · Aged 65+Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Respiratory register validation and asthma recall (p12)COPD register · COPD: QOF prevalence · Asthma registerCore20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15